1. BASELINE CLINICAL AND PET‐CT TUMOR BURDEN PARAMETERS DO NOT PREDICT OUTCOME OF RELAPSE/REFRACTORY AGGRESSIVE B CELL LYMPHOMA PATIENTS TREATED WITH ANTI‐CD19 CAR T‐CELLS. (12th June 2019) Authors: Avigdor, A.; Davidson, T.; Shimoni, A.; Yerushalmi, R.; Shem‐Tov, N.; Danylesko, I.; Itzhaki, O.; Toren, A.; Jacoby, E.; Besser, M.; Nagler, A. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 504 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CONSOLIDATION RADIOTHERAPY COULD BE OMITTED IN ADVANCED HODGKIN LYMPHOMA WITH LARGE NODAL MASS IN COMPLETE METABOLIC RESPONSE AFTER ABVD. FINAL ANALYSIS OF THE RANDOMIZED HD0607 TRIAL. (12th June 2019) Authors: Gallamini, A.; Rossi, A.; Patti, C.; Picardi, M.; Romano, A.; Cantonetti, M.; Oppi, S.; Viviani, S.; Bolis, S.; Trentin, L.; Gini, G.; Battistini, R.; Chauvie, S.; Bertolotti, L.; Pavoni, C.; Parvis, G.; Zanotti, R.; Gavarotti, P.; Cimminiello, M.; Schiavotto, C. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. IBRUTINIB INCREASES THE SYSTEMIC EXPOSURE OF RITUXIMAB: PHARMACOKINETIC RESULTS FROM THE HELIOS TRIAL. (June 2017) Authors: Cramer, P.; Demirkan, F.; Fraser, G.; Pristupa, A.; Bartlett, N.; Dilhuydy, M.; Loscertales, J.; Avigdor, A.; Rule, S.; Samoilova, O.; Goy, A.; Ganguly, S.; Poggesi, I.; Lavezzi, S.M.; De Nicolao, G.; de Jong, J.; Neyens, M.; Salman, M.; Howes, A.; Mahler, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P1086: FAVEZELIMAB (ANTI–LAG-3) AND PEMBROLIZUMAB CO-BLOCKADE IN ANTI–PD-1–NAIVE PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA: AN OPEN-LABEL PHASE 1/2 STUDY. (23rd June 2022) Authors: Gregory, G.; Timmerman, J.; Lavie, D.; Borchmann, P.; Herrera, A. F.; Minuk, L.; Vucinic, V.; Armand, P.; Avigdor, A.; Gasiorowski, R.; Herishanu, Y.; Keane, C.; Kuruvilla, J.; Palcza, J.; Pillai, P.; Marinello, P.; Johnson, N. A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 976 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P1087: FAVEZELIMAB (ANTI–LAG-3) AND PEMBROLIZUMAB CO-BLOCKADE IN PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA WHO PROGRESSED AFTER ANTI–PD-1 THERAPY: AN OPEN-LABEL PHASE 1/2 STUDY. (23rd June 2022) Authors: Herrera, A. F.; Lavie, D.; Johnson, N. A.; Avigdor, A.; Borchmann, P.; Andreadis, C.; Bazargan, A.; Gregory, G.; Keane, C.; Inna, T.; Vucinic, V.; Zinzani, P. L.; Zhang, H.; Pillai, P.; Marinello, P.; Timmerman, J. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 977 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P1108: HIGH COMPLETE RESPONSE RATE FOLLOWING POINT-OF-CARE ANTI CD19 CAR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA. (23rd June 2022) Authors: Fried, S.; Besser, M. J.; Shkury, E.; Yerushalmi, R.; Shem-Tov, N.; Danylesko, I.; Jacoby, E.; Itzhaki, O.; Shouval, R.; Kedmi, M.; Shimoni, A.; Nagler, A.; Avigdor, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 998 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P1571: EVALUATION OF THE CLINICAL IMPACT OF BONE MARROW CULTURES IN CURRENT MEDICAL PRACTICE. (23rd June 2022) Authors: Sharvit, G.; Schwartz, D.; Heering, G.; Shulman, A.; Avigdor, A.; Rahav, G.; Toren, A.; Nagler, A.; Canaani, J. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1452 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PB1809: CLINICAL TRAJECTORY OF LONG-TERM SURVIVORS OF ACUTE MYELOID LEUKEMIA TREATED WITH INTENSIVE INDUCTION CHEMOTHERAPY. (23rd June 2022) Authors: Heering, G.; Sasson, M.; Dominissini, D.; Shimoni, A.; Avigdor, A.; Nagler, A.; Canaani, J. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1689 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗